Humanized AXL antibodies

Details for Australian Patent Application No. 2010247464 (hide)

Owner U3 Pharma GmbH

Inventors Wirtz, Peter; Ruhe, Jens; Takizawa, Takeshi; Takayama, Tomoko

Agent Davies Collison Cave

Pub. Number AU-A-2010247464

PCT Pub. Number WO2010/130751

Priority 09006474.2 13.05.09 EP; 09006355.3 11.05.09 EP

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/282 (2006.01)

A61K 31/704 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/130751 Priority application(s): WO2010/130751

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247466-Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles

2010247461-Method for identifying inhibitors against dengue virus